DEA acknowledges new standard for designating medical value of drugs

The new two-step test was initiated by the U.S. Department of Health and Human Services during its evaluation of cannabis rescheduling.

The post DEA acknowledges new standard for designating medical value of drugs appeared first on Green Market Report.